TO LEARN MORE ABOUT RADICAVA®, SPEAK WITH A JOURNEYMATE RESOURCE SPECIALIST 1-855-457-6968. SEE MORE
TO LEARN MORE ABOUT RADICAVA®, SPEAK WITH A JOURNEYMATE RESOURCE SPECIALIST 1-855-457-6968. SEE MORE
Can RADICAVA® help slow the loss of physical function?
If you have just been diagnosed, when can treatment with RADICAVA ORS® or RADICAVA® IV begin?
If switching from one option to another, how can treatment be started?
The Steps on Your Way to Treatment for RADICAVA ORS® or RADICAVA® IV patient brochure explains the steps you and your doctor may need to take to start or switch to RADICAVA ORS® or RADICAVA® IV.
It's also helpful to know that there are clinical studies that allow patients to continue taking edaravone while on study treatment.
Download the Talk to Your Doctor Discussion Guide.
Have questions about starting treatment?
Call a JourneyMate Resource Specialist at 1-855-457-6968 between 9 AM and 9 PM ET, Monday through Friday.
Have you already been prescribed RADICAVA®? The Getting Started With RADICAVA ORS® video can give you helpful information.
Watch now
Whether you and your doctor have decided on RADICAVA ORS® or RADICAVA® IV, or you're considering treatment, the first step is to complete a BIF with your doctor, which includes your signature. Or you can start by completing a Patient Authorization Form.
Once you've been prescribed RADICAVA ORS® or RADICAVA® IV, signing the Patient Authorization helps you connect to patient-focused answers and resources.
You can help by filling out part of the form now.
Download the Benefits Investigation and Enrollment Form
Type your Patient Information on page 3 using your computer, or print and complete by hand
Review the form to make sure the information is correct. Then print it, if you didn't do so earlier
Sign page 3 of the BIF after you read page 4
Bring it to your doctor, who will need to complete and also sign the BIF
Your doctor will complete the rest of the form and send it to an Insurance & Access Specialist. Do NOT send the BIF yourself.
Online via eSignAccess the eSign form
Follow instructions for submitting the online form
By Fax or MailDownload and save the editable
Patient Authorization Form
Print, complete and sign the form
Fax it to 1-888-782-6157 or mail it to:
JourneyMate Support Program™
Insurance & Access Specialist
680 Century Point
Lake Mary, FL 32746
A JourneyMate Support Program™ Insurance & Access Specialist will call you to:
Explain your health plan coverage
Inform you about financial support options, such as the Out-of-Pocket Assistance Program, if eligibleb (see footnote)
You may also receive a call from a Clinical Educator, who can provide:
Personalized education to you and your family about RADICAVA ORS® or RADICAVA® IV
Resources to help you throughout your treatment
Prescriptions for RADICAVA ORS® are sent to an in-network specialty pharmacy, which may assist your doctor in obtaining a final coverage determination.
The specialty pharmacy will call you to:
Confirm approval of coverage and payment
Apply available financial support, if eligible
Schedule delivery of RADICAVA ORS® to you
If RADICAVA ORS® or RADICAVA® IV isn't covered, you can request an exception from your health plan. For helpful steps to submit an exception, download Requesting an Exception From Your Health Plan.
If an exception is denied, your doctor may be able to help appeal the decision. Having your doctor file an appeal may help give the insurance provider more details about why you should receive treatment. A next-level appeal may also be required if your request is denied.
Once coverage has been established, you can receive your prescription in one of two ways, depending on the treatment option.
Contact you to review coverage details and helps obtain a coverage determination from your health plan
Obtain from you and your doctor any additional information required to confirm approval of your health insurance coverage
Coordinate with the Insurance & Access Specialist to provide you and your doctor with a final benefit summary
When approval of coverage is confirmed and payment is secured, the specialty pharmacy applies available financial support, if eligible, and schedules delivery of RADICAVA ORS® to you.
For more information, download Receiving RADICAVA ORS® from a Specialty Pharmacy
A specialty pharmacy
An infusion therapy provider
A home infusion provider
When approval of coverage is confirmed, your infusion provider schedules your treatment with RADICAVA® IV.
How you receive your treatment and how it is covered can determine your out-of-pocket costs. If you have been prescribed RADICAVA ORS® or RADICAVA® IV, it may be important to understand health plan coverage benefits.
Learn more by downloading the Understanding Your Coverage and Costs for Treatment Brochure.
The ALS Care Locator is designed for the ALS community to help locate services for the treatment of ALS. It can help you:
Find neurologists and other doctors who treat ALS
Search for infusion services capable of administering RADICAVA® IV, for example:
Type of facility, location, insurance accepted, including Medicare
Languages spoken, hours of operation, amenities
Find doctors who treat ALS closest to you.
Visit the ALS Care Locator
The ALS Care Locator is an informational resource only regarding available treatment providers. The providers listed in the directory are under no obligation to provide treatment.
The ALS Care Locator is a directory with a number of functions, including a directory of providers that treat ALS and who have opted-in to participate in the directory. This submission information is updated on a monthly basis.
Providers listed in the directory are not affiliated with Mitsubishi Tanabe Pharma America, Inc. and do not pay to be on the list. No fees or remuneration of any kind have been or will be exchanged for participation in the ALS Care Locator. Inclusion of a provider in the ALS Care Locator does not constitute a referral, recommendation, endorsement, or verification of credentials, qualifications, or abilities of the provider listed. Similarly, the absence of a provider's name and information should not be construed as a negative comment from Mitsubishi Tanabe Pharma America, Inc. about the provider's credentials, qualifications, or abilities.
Mitsubishi Tanabe Pharma America, Inc., as well as its employees or agents, shall not be held liable for any damages or harm resulting from any use or reliance on information contained in the ALS Care Locator, and may modify, amend, remove or cancel the ALS Care Locator at any time without notice.
If you are an HCP who treats ALS, including a neurologist and those at a multidisciplinary center, and would like to be added to the ALS Care Locator, please contact LocatorQuestions@mt-pharma-us.com, or if you would like to be removed from the ALS Care Locator, please contact LocatorOptOut@mt-pharma-us.com.
If you are an infusion service provider who has experience administering RADICAVA® IV and would like to be added to the ALS Care Locator, or if you are listed in the ALS Care Locator and would like to be removed, please contact the JourneyMate Support Program™ Insurance & Access Specialist at 1-844-772-4548.
A JourneyMate Support Program™ Insurance & Access Specialist is provided by UBC on behalf of Mitsubishi Tanabe Pharma America, Inc. (MTPA). A JourneyMate Support Program™ Insurance & Access Specialist may provide information obtained from outside sources about a patient's insurance coverage, financial support options, and whether treatment is covered by their health plan. This information does not require a patient or their doctor to use any MTPA product. Because the information provided comes from outside sources, a JourneyMate Support Program™ Insurance & Access Specialist cannot guarantee the information will be accurate or complete.
An ALS Clinical Educator is an educational resource for patients who have been prescribed RADICAVA ORS® or RADICAVA® IV. An ALS Clinical Educator is provided by Mitsubishi Tanabe Pharma America, Inc. and VMS and is not affiliated with or provided by a doctor. An ALS Clinical Educator does not provide medical advice. All questions about a condition, diagnosis, or treatment should be referred to a patient’s doctor.
aA prescription or a BIF for RADICAVA ORS® of RADICAVA® IV needs to be obtained in order for JourneyMate Support Program™ to provide resources. Return to content
bThis is not insurance. The Out-of-Pocket Assistance Program is for eligible patients who have commercial insurance that covers a portion of the medication costs for RADICAVA ORS® (edaravone). Support is not valid for patients covered, in whole or in part, by government-funded health insurance such as Medicare, Medicaid, VA, DoD, or other federal or state assistance programs. Other restrictions apply. See full Eligibility Requirements & Terms and Conditions available at radicava.com. Return to content
Do not receive RADICAVA (edaravone) or RADICAVA ORS (edaravone) if you are allergic to edaravone or any of the ingredients in RADICAVA and RADICAVA ORS.
Before you take RADICAVA or RADICAVA ORS, tell your healthcare provider about all of your medical conditions, including if you:
have asthma.
are allergic to other medicines.
are pregnant or plan to become pregnant. It is not known if RADICAVA or RADICAVA ORS will harm your unborn baby.
are breastfeeding or plan to breastfeed. It is not known if RADICAVA or RADICAVA ORS passes into your breastmilk. You and your healthcare provider should decide if you will receive RADICAVA or RADICAVA ORS or breastfeed.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of RADICAVA and RADICAVA ORS?
RADICAVA and RADICAVA ORS may cause serious side effects, including hypersensitivity (allergic) reactions and sulfite allergic reactions.
Hypersensitivity reactions have happened in people receiving RADICAVA or taking RADICAVA ORS and can happen after your medicine has been given.
RADICAVA and RADICAVA ORS contain sodium bisulfite, a sulfite that may cause a type of allergic reaction that can be serious and life-threatening. Sodium bisulfite can also cause less severe asthma episodes in certain people. Sulfite sensitivity can happen more often in people who have asthma than in people who do not have asthma.
Tell your healthcare provider right away or go to the nearest emergency room if you have any of the following symptoms: hives; swelling of the lips, tongue, or face; fainting; breathing problems; wheezing; trouble swallowing; dizziness; itching; or an asthma attack (in people with asthma).
Your healthcare provider will monitor you during treatment to watch for signs and symptoms of all the serious side effects and allergic reactions.
The most common side effects include bruising (contusion), problems walking (gait disturbance) and headache.
These are not all the possible side effects of RADICAVA or RADICAVA ORS. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to www.fda.gov/medwatch or Mitsubishi Tanabe Pharma America, Inc. at 1-888-292-0058.
INDICATION
RADICAVA and RADICAVA ORS are indicated for the treatment of amyotrophic lateral sclerosis (ALS).
Please see full Prescribing Information and Patient Information.
Do not receive RADICAVA (edaravone) or RADICAVA ORS (edaravone) if you are allergic to edaravone or any of the ingredients in RADICAVA and RADICAVA ORS.
Before you take RADICAVA or RADICAVA ORS, tell your healthcare provider about all of your medical conditions, including if you:
have asthma.
are allergic to other medicines.
are pregnant or plan to become pregnant. It is not known if RADICAVA or RADICAVA ORS will harm your unborn baby.
are breastfeeding or plan to breastfeed. It is not known if RADICAVA or RADICAVA ORS passes into your breastmilk. You and your healthcare provider should decide if you will receive RADICAVA or RADICAVA ORS or breastfeed.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of RADICAVA and RADICAVA ORS?
RADICAVA and RADICAVA ORS may cause serious side effects, including hypersensitivity (allergic) reactions and sulfite allergic reactions.
Hypersensitivity reactions have happened in people receiving RADICAVA or taking RADICAVA ORS and can happen after your medicine has been given.
RADICAVA and RADICAVA ORS contain sodium bisulfite, a sulfite that may cause a type of allergic reaction that can be serious and life-threatening. Sodium bisulfite can also cause less severe asthma episodes in certain people. Sulfite sensitivity can happen more often in people who have asthma than in people who do not have asthma.
Tell your healthcare provider right away or go to the nearest emergency room if you have any of the following symptoms: hives; swelling of the lips, tongue, or face; fainting; breathing problems; wheezing; trouble swallowing; dizziness; itching; or an asthma attack (in people with asthma).
Your healthcare provider will monitor you during treatment to watch for signs and symptoms of all the serious side effects and allergic reactions.
The most common side effects include bruising (contusion), problems walking (gait disturbance) and headache.
These are not all the possible side effects of RADICAVA or RADICAVA ORS. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to www.fda.gov/medwatch or Mitsubishi Tanabe Pharma America, Inc. at 1-888-292-0058.
INDICATION
RADICAVA and RADICAVA ORS are indicated for the treatment of amyotrophic lateral sclerosis (ALS).
Please see full Prescribing Information and Patient Information.
RADICAVA, RADICAVA ORS, the RADICAVA logo, and the corporate symbol of Mitsubishi Tanabe Pharma America are registered trademarks, and the RADICAVA ORS logo is a trademark, of Mitsubishi Tanabe Pharma Corporation.
JourneyMate Support Program is a trademark of Mitsubishi Tanabe Pharma America, Inc.
All other company names, product names, trade/service marks or other trade names are the property of their respective owners.
For US audiences only.
© 2023 Mitsubishi Tanabe Pharma America, Inc. All rights reserved. CP-OE-US-0128 05/23
You are leaving this website, hosted by Mitsubishi Tanabe Pharma America.
This link may take you to a website to which our Privacy Policy does not apply.
Mitsubishi Tanabe Pharma America does not control the content of third-party sites.
The information in this section is intended for patients who have spoken to their doctor about starting RADICAVA ORS® or RADICAVA® IV or have been prescribed RADICAVA ORS® or RADICAVA® IV.
